INC Research Becomes Global Impact Partner with Society for Clinical Research Sites
INC Research announced a two-year partnership with the Society for Clinical Research Sites.
INC Research, a global Phase I to IV clinical research organization (CRO), announced a two-year partnership with the Society for Clinical Research Sites (SCRS), a global trade organization fully dedicated to representing the interests of clinical research sites. INC will participate as a Global Impact Partner (GIP), the highest level of membership within SCRS. GIPs participate on the SCRS Global Impact Board at an executive level. Working in tandem with SCRS’ Leadership Council, the Board helps set strategic initiatives for the Society, which advocates, connects, educates, and mentors more than 1,400 sites represented across 22 countries.
Read the full release
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Related Articles
- Everything to Know About FDA’s Push Towards Radical Transparency in 2025
September 17th 2025
- IQVIA and Veeva Join Forces to Improve Efficiency and Patient Outcomes
September 17th 2025
- Managing Background Therapies in the NIMBLE Phase III Trial
September 17th 2025
- Generative AI Transforms Clinical Study Report Development
September 16th 2025